The June 2020 edition is live.

Our June issue goes live today, the super-size edition covers infectious diseases including vaccines, regenerative medicine and biopharma dealmaking.

Like Comment

Our June issue goes live today, the super-size edition includes companies and editorial features focused upon infectious diseases including vaccines, regenerative medicine and biopharma dealmaking. 

Read the full issue here.

Editorial features in-depth - 

  • Next-generation therapeutics sustain momentum  
  • Partnering for a pandemic
  • Dealmaking in 2020: navigating a new landscape   
Go to the profile of Raveena Bhambra

Raveena Bhambra

Editor, BioPharma Dealmakers , Nature Research

Hello all, I am the Editor of BioPharma Dealmakers, a quarterly publication that assists companies in identifying potential partners in the pharmaceutical and biotechnology industry and appears in both Nature Biotechnology and Nature Reviews Drug Discovery. I am very passionate about the biopharma industry and have over 15 years of experience of working in the field, specifically in dealmaking, partnering and licensing. In my previous roles I have conducted partner searches identifying both products/technologies and partners for clients, and have edited and written dealmaking-focused reports.

No comments yet.